2026 Gabriel Lopez-Berestein: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	112	5086	4772	2753	2551	580	56316

Overview

Gabriel Lopez-Berestein is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research activity spans key areas in biochemistry, genetics, molecular biology, and medicine, with a particular focus on molecular biology, cancer research, oncology, immunology, and pulmonary and respiratory medicine.

The scientist's main fields of study include:

Biochemistry, Genetics and Molecular Biology
Medicine

Their subfields of study cover:

Molecular Biology
Cancer Research
Oncology
Immunology
Pulmonary and Respiratory Medicine

Their research topics frequently address areas such as:

MicroRNA in disease regulation
Cancer-related molecular mechanisms research
RNA modifications and cancer
RNA Interference and Gene Delivery
Angiogenesis and VEGF in Cancer
Advanced biosensing and bioanalysis techniques
RNA Research and Splicing

Gabriel Lopez-Berestein has been published multiple times in notable scientific venues. Frequent publication venues include:

Cancer Research
Cell Reports
Cancers
UNC Libraries
Nature Communications

Some recent papers authored or coauthored by Lopez-Berestein include:

GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma, 2020, Cellular Signalling
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity, 2021, Journal of the American Chemical Society
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer, 2020, Gut
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update, 2023, Non-Coding RNA
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site, 2021, Cell Reports

Their frequent co-authors are:

Cristian Rodriguez-Aguayo
Anil K. Sood
Lingegowda S. Mangala
Cristina Ivan
Emine Bayraktar

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

8665
Citations
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Daniel J. Klionsky;Hagai Abeliovich;Patrizia Agostinis;Devendra K. Agrawal

2934
Citations
MicroRNAs in body fluids—the mix of hormones and biomarkers

Maria Angelica Cortez;Carlos E. Bueso-Ramos;Jana Ferdin;Gabriel Lopez-Berestein

1651
Citations
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Premal H Thaker;Liz Y Han;Aparna A Kamat;Jesusa M Arevalo

1519
Citations
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery

Charles N. Landen;Arturo Chavez-Reyes;Corazon Bucana;Rosemarie Schmandt

982
Citations
RNA interference in the clinic: challenges and future directions

Chad V. Pecot;George A. Calin;Robert L. Coleman;Gabriel Lopez-Berestein

941
Citations
Dicer, Drosha, and outcomes in patients with ovarian cancer

William M. Merritt;Yvonne G. Lin;Liz Y. Han;Aparna A. Kamat

880
Citations
Paraneoplastic Thrombocytosis in Ovarian Cancer

Rebecca L. Stone;Alpa M. Nick;Iain A. McNeish;Frances Balkwill

844
Citations
Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas;Luis H. Camacho;Gabriel Lopez-Berestein;Dmitri Pavlov

697
Citations
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

Rajesha Rupaimoole;George A. Calin;Gabriel Lopez-Berestein;Anil K. Sood

619
Citations
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta

539
Citations
Preclinical and clinical development of siRNA-based therapeutics

Gulnihal Ozcan;Bulent Ozpolat;Robert L. Coleman;Anil K. Sood

531
Citations
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer.

Kevin N. Dalby;Ibrahim Tekedereli;Gabriel Lopez-Berestein;Bulent Ozpolat

503
Citations
Liposomal siRNA nanocarriers for cancer therapy

Bulent Ozpolat;Anil K. Sood;Gabriel Lopez-Berestein

494
Citations
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

Charles N. Landen;Blake Goodman;Ashwini A. Katre;Adam D. Steg;Adam D. Steg

457
Citations
Regulation of Tumor Angiogenesis by EZH2

Chunhua Lu;Hee Dong Han;Lingegowda S. Mangala;Rouba Ali-Fehmi

445
Citations
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

Da Yang;Yan Sun;Yan Sun;Limei Hu;Hong Zheng;Hong Zheng

442
Citations
Tumour angiogenesis regulation by the miR-200 family

Chad V. Pecot;Rajesha Rupaimoole;Da Yang;Rehan Akbani

430
Citations
microRNA Therapeutics in Cancer — An Emerging Concept

Maitri Y. Shah;Alessandra Ferrajoli;Anil K Sood;Gabriel Lopez-Berestein

425
Citations
Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

William M. Merritt;Yvonne G. Lin;Whitney A. Spannuth;Mavis S. Fletcher

325
Citations

Frequent Co-Authors

Anil K. Sood The University of Texas MD Anderson Cancer Center

Cristian Rodriguez-Aguayo The University of Texas MD Anderson Cancer Center

George A. Calin The University of Texas MD Anderson Cancer Center

Kapil Mehta MolQ Laboratory

Robert L. Coleman The University of Texas MD Anderson Cancer Center

Susan K. Lutgendorf University of Iowa

Jinsong Liu The University of Texas MD Anderson Cancer Center

Keith A. Baggerly The University of Texas MD Anderson Cancer Center

Charles N. Landen University of Virginia

Mien Chie Hung China Medical University

External Links

Personal website of Gabriel Lopez-Berestein

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

If you’re interested in studying medicine in the USA, there are several related online degree programs and career pathways to consider. Pursuing a healthcare administration accelerated degree is a smart choice if you want to quickly advance into management and leadership roles within healthcare organizations. These programs often allow students to complete their studies faster than traditional paths.

For registered nurses aiming to expand their scope of practice, asn to fnp programs provide a flexible way to bridge from an Associate's Degree in Nursing to a Family Nurse Practitioner credential, opening new doors in advanced nursing care.

Individuals passionate about health and wellness might consider an bachelor's in nutrition online, which prepares graduates for roles in public health, wellness coaching, and clinical nutrition.

Deciding which pathway is right for you often means understanding program quality. Learn how to evaluate healthcare administration degree programs to ensure your chosen degree has the right accreditation and meets your career goals.